Source: Annual Congress 2007 - Airway regulation, provocation and monitoring - III
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Fregonese, F. Ferrari, M. Fumagalli, P. Sterk, P. Iadarola, M. Luisetti, J. Stolk (Leiden, Netherlands; Pavia, Italy). Ventilation inhomogeneity is correlated with biomarkers of parenchymal destruction in alpha1 antitrypsin deficiency. Eur Respir J 2007; 30: Suppl. 51, 3637

Member's Comments

No comment yet.

Related content which might interest you: Lung function in relation to emphysema development in alpha-1 antitrypsin deficiency Source: International Congress 2019 – Insights into physiological diagnostic services Year: 2019 Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease. Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019 Z antitrypsin polymerization is associated with enhanced pulmonary inflammation Source: Annual Congress 2012 - Novel mechanisms of acute lung injury Year: 2012 Change in lung function and CT lung density in alpha1 antitrypsin deficiency patients under augmentation therapy Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 The prognostic value of CT-based lung density histograms in patients with severe alpha-1 antitrypsin deficiency Source: Eur Respir J 2004; 24: Suppl. 48, 296s Year: 2004 Exercise intolerance and lung emphysema in alpha-1 antitrypsin deficiency (AATD) Source: Annual Congress 2010 - Exercise in COPD Year: 2010 Clinical features of alpha one antitrypsin deficiency in non cystic fibrosis bronchiectasis Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Alveolar nitric oxide correlates with lung volumes in patients with emphysema and Alpha-1 antitrypsin deficiency (AATD) Source: Eur Respir J 2006; 28: Suppl. 50, 223s Year: 2006 Monitoring disease progression in severe Alpha1 antitrypsin deficiency Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD Year: 2020 Clinical features of alpha one antitrypsin deficiency in COPD Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Screening of chronic liver disease by transient elastography in patients with lung disease associated with alpha-1 antitrypsin deficiency. Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Abnormal collagen type V deposition in lung fibroblast is correlated with a worse pulmonary function in systemic sclerosis Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 COPD and alpha-1 antitrypsin deficiency emphysema: characteristics and survival after Lung Transplantation Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 Use of measurements of airway resistance in the determination of reversibility in patients with emphysema associated with alpha-1-antitrypsin (A1ATD) deficiency Source: Eur Respir J 2001; 18: Suppl. 33, 205s Year: 2001 The use of impulse oscillometry (IOS) in the differentiation of bronchiectasis and emphysema in patients with alpha1 antitrypsin deficiency (α1-ATD) Source: Annual Congress 2004 - Airway resistance: application and technique Year: 2004 The relationship of small airways disease to spirometry and emphysema in alpha-1 antitrypsin deficiency Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Specific airway resistance as a marker of early disease in alpha-1 antitrypsin deficiency Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 Long-term changes of elastin breakdown products in alpha-1 antitrypsin deficiency Source: Eur Respir J 2007; 30: Suppl. 51, 139s Year: 2007 Alpha 1 antitrypsin (A1AT) deficiency among patients with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 501s Year: 2003 Endobronchial valve treatment in patients with severe emphysema due to alpha-1 antitrypsin deficiency. Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease Year: 2019